MAGE-A1-derived peptide
Product Specifications
UNSPSC Description
MAGE-A1-derived peptide is a short peptide sequence derived from MAGE-A1 protein. As a tumor-specific antigen, MAGE-A1-derived peptide can be recognized and activated by cytotoxic T lymphocytes (CTLs), thereby generating an immune response to tumor cells expressing MAGE-A1. This immune response can lead to the lysis and death of tumor cells. MAGE-A1-derived peptide can be used in the study of tumor immunity[1].
Target Antigen
Others
Type
Peptides
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mage-a1-derived-peptide.html
Smiles
O=C(N[C@@H](C(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](C(C)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCCN)N
Molecular Weight
1090.36
References & Citations
[1]Ottaviani S, et al. A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells[J]. Cancer Immunology, Immunotherapy, 2005, 54: 1214-1220.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P10496/MAGE-A1-derived-peptide-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P10496/
Clinical Information
No Development Reported
CAS Number
160213-30-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6195888-01 0.1 mL
HCLS1 (Hematopoietic Cell-Specific Lyn Substrate 1, CTTNL, HS1) (MaxLight 405)
Ask
View Details 
MBS6195888-02 5x 0.1 mL
HCLS1 (Hematopoietic Cell-Specific Lyn Substrate 1, CTTNL, HS1) (MaxLight 405)
Ask
View Details